123 related articles for article (PubMed ID: 30855705)
1. Quantitative volumetric analysis of primary glioblastoma multiforme on MRI and 11C-methionine PET: initial study on five patients.
Zhao J; Chen Z; Cai L; Yin S; Yang W; Wang Z
Neurol Neurochir Pol; 2019; 53(3):199-204. PubMed ID: 30855705
[TBL] [Abstract][Full Text] [Related]
2. Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.
Kawai N; Maeda Y; Kudomi N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):441-50. PubMed ID: 21072512
[TBL] [Abstract][Full Text] [Related]
3. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
[TBL] [Abstract][Full Text] [Related]
4. Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study.
Miwa K; Shinoda J; Yano H; Okumura A; Iwama T; Nakashima T; Sakai N
J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1457-62. PubMed ID: 15377696
[TBL] [Abstract][Full Text] [Related]
5. Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme.
Galldiks N; Ullrich R; Schroeter M; Fink GR; Jacobs AH; Kracht LW
Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):84-92. PubMed ID: 19662410
[TBL] [Abstract][Full Text] [Related]
6. Quantitative volumetric analysis of gliomas with sequential MRI and ¹¹C-methionine PET assessment: patterns of integration in therapy planning.
Arbizu J; Tejada S; Marti-Climent JM; Diez-Valle R; Prieto E; Quincoces G; Vigil C; Idoate MA; Zubieta JL; Peñuelas I; Richter JA
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):771-81. PubMed ID: 22258713
[TBL] [Abstract][Full Text] [Related]
7. l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.
Mahasittiwat P; Mizoe JE; Hasegawa A; Ishikawa H; Yoshikawa K; Mizuno H; Yanagi T; Takagi R; Pattaranutaporn P; Tsujii H
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):515-22. PubMed ID: 17900820
[TBL] [Abstract][Full Text] [Related]
8. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
[TBL] [Abstract][Full Text] [Related]
9. Met-PET uptake index for total tumor resection: identification of
Inoue A; Ohnishi T; Kohno S; Ohue S; Nishikawa M; Suehiro S; Matsumoto S; Ozaki S; Fukushima M; Kurata M; Kitazawa R; Shigekawa S; Watanabe H; Kunieda T
Neurosurg Rev; 2021 Feb; 44(1):587-597. PubMed ID: 32060762
[TBL] [Abstract][Full Text] [Related]
10. The Application of Magnetic Resonance Imaging-Deformed 11C-Methionine-Positron Emission Tomography Images in Stereotactic Radiosurgery.
Jung TY; Jung S; Ryu HS; Kim IY; Jang WY; Moon KS; Lim SH; Kim DY; Kang SR; Min JJ; Bom HS; Kim SK; Kwon SY
Stereotact Funct Neurosurg; 2019; 97(4):217-224. PubMed ID: 31694035
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of intraoperative perfusion-weighted MRI and 5-aminolevulinic acid in relation to contrast-enhanced intraoperative MRI and
Pala A; Reske SN; Eberhardt N; Scheuerle A; König R; Schmitz B; Beer AJ; Wirtz CR; Coburger J
Neurosurg Rev; 2019 Jun; 42(2):471-479. PubMed ID: 29808321
[TBL] [Abstract][Full Text] [Related]
12. [11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme.
Pötzi C; Becherer A; Marosi C; Karanikas G; Szabo M; Dudczak R; Kletter K; Asenbaum S
J Neurooncol; 2007 Sep; 84(3):305-14. PubMed ID: 17492401
[TBL] [Abstract][Full Text] [Related]
13. A comparison study of dynamic [
Pan Y; Dang H; Zhou H; Fu H; Wu S; Liu H; Zhang J; Wang R; Tian Y; Xu B
J Cancer Res Clin Oncol; 2024 Apr; 150(4):208. PubMed ID: 38647690
[TBL] [Abstract][Full Text] [Related]
14. Target definition by C11-methionine-PET for the radiotherapy of brain metastases.
Matsuo M; Miwa K; Shinoda J; Kako N; Nishibori H; Sakurai K; Yano H; Iwama T; Kanematsu M
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):714-22. PubMed ID: 19095373
[TBL] [Abstract][Full Text] [Related]
15. Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme.
Lee IH; Piert M; Gomez-Hassan D; Junck L; Rogers L; Hayman J; Ten Haken RK; Lawrence TS; Cao Y; Tsien C
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):479-85. PubMed ID: 18834673
[TBL] [Abstract][Full Text] [Related]
16. Dissociation Between 11C-Methionine-Positron Emission Tomography and Gadolinium-Enhanced Magnetic Resonance Imaging in Longitudinal Features of Glioblastoma After Postoperative Radiotherapy.
Kawasaki T; Miwa K; Shinoda J; Asano Y; Takei H; Ikegame Y; Yokoyama K; Yano H; Iwama T
World Neurosurg; 2019 May; 125():93-100. PubMed ID: 30716494
[TBL] [Abstract][Full Text] [Related]
17. Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI: a feasibility study.
Deuschl C; Moenninghoff C; Goericke S; Kirchner J; Köppen S; Binse I; Poeppel TD; Quick HH; Forsting M; Umutlu L; Herrmann K; Hense J; Schlamann M
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1285-1295. PubMed ID: 28258444
[TBL] [Abstract][Full Text] [Related]
18. Metabolic delineation of IDH1 wild-type glioblastoma surgical anatomy: how to plan the tumor extent of resection.
Altieri R; Certo F; Pacella D; Cammarata G; Garozzo M; Broggi G; Caltabiano R; Magro G; Russo G; Cosentino S; Ippolito M; Barbagallo G
J Neurooncol; 2023 Apr; 162(2):417-423. PubMed ID: 37039952
[TBL] [Abstract][Full Text] [Related]
19. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K
J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344
[TBL] [Abstract][Full Text] [Related]
20. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
